Molecular Biophysics
The Impact of Race and Sex on Metastatic Bladder Cancer Survival
To characterize the epidemiological profile of metastatic bladder cancer (BC) and assess mortality rate with respect to race and gender across the three most common histologies of bladder cancer—Transitional Cell Carcinoma, Adenocarcinoma, and SCC (Squamous Cell Carcinoma).Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2
We read with great interest the recent work of Pierre-Victor et al on prostate cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.1 We previously reported, in 2017, on a similar cohort from this trial.2 We studied men in the screening arm who screened positive (via prostate-specific antigen or digital rectal exam) during the first year of the trial, and whose linked biopsy was negative. We found a similar mortality rate after a median follow-up of 12.9 years of 1.1% (vs 1.2% in the present study).
